Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Dopamine agonist" patented technology

A dopamine receptor agonist (DA) is a compound that activates dopamine receptors. There are two families of dopamine receptors, D₂-like and D₁-like, and they are all G protein-coupled receptors. D₁- and D₅-receptors belong to the D₁-like family and the D₂-like family includes D₂, D₃ and D₄ receptors. The DA are used in Parkinson’s disease and, to a lesser extent, to treat depression, hyperprolactinemia and restless leg syndrome.

Combination therapy for a dopamine agonist

PendingUS20260144776A1Nervous disorderDigestive systemOndansetronDopamine
The application describes a method of reducing emesis caused by a dopamine agonist in a patient with depression who is treated with a dopamine agonist, comprising administering ondansetron in combination with the dopamine agonist.
Owner:ALTO NEUROSCIENCE INC

Combination therapy for a dopamine agonist

ActiveUS12521374B1Nervous disorderDigestive systemOndansetronDopamine
The application describes a method of reducing emesis caused by a dopamine agonist in a patient with depression who is treated with a dopamine agonist, comprising administering ondansetron in combination with the dopamine agonist.
Owner:ALTO NEUROSCIENCE INC

Combination therapy for a dopamine agonist

ActiveUS12648934B2Nervous disorderDigestive systemOndansetronDopamine
The application describes a method of reducing emesis caused by a dopamine agonist in a patient with depression who is treated with a dopamine agonist, comprising administering ondansetron in combination with the dopamine agonist.
Owner:ALTO NEUROSCIENCE INC

Use of nicotinic acetylcholine receptor alpha 7 activators

ActiveCN110051670BOrganic active ingredientsNervous disorderDopamineDopamine agonist
The present invention relates to the use of nicotinic acetylcholine receptor alpha 7 activators, in particular to the use of nicotinic acetylcholine receptor alpha 7 agonists for the treatment, prevention or delay of progression of dyskinesia associated with dopamine agonist therapy in Parkinson's disease.
Owner:NOVARTIS AG

Combination therapy for a dopamine agonist

ActiveUS20260069573A1Nervous disorderDigestive systemOndansetronDopamine
The application describes a method of reducing emesis caused by a dopamine agonist in a patient with depression who is treated with a dopamine agonist, comprising administering ondansetron in combination with the dopamine agonist.
Owner:ALTO NEUROSCIENCE INC